Gilbert & Cook’s Celgene Corp CELG Stock Holding History

Gilbert & Cook’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,938	Closed	-$381K	–	145
2017 Q2	$381K	Buy	+2,938	New	+$360K	0.13%	72

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Gilbert & Cook's CELG Position: Q3 2017 in Review

Gilbert & Cook sold out of Celgene Corp (CELG) in Q3 2017, closing a stake of 2,938 shares — an estimated $381K sold.

Gilbert & Cook first reported a position in CELG in Q2 2017 and held it in 1 quarter. The position peaked at $381K in Q2 2017. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

Gilbert & Cook reported no remaining Celgene Corp position as of Q3 2017 after selling out during the quarter.
Gilbert & Cook sold 2,938 Celgene Corp shares in Q3 2017, an estimated $381K.
Gilbert & Cook first reported a position in Celgene Corp in Q2 2017 and held it in 1 quarter.
Gilbert & Cook's Celgene Corp position peaked at $381K in Q2 2017.
1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on Gilbert & Cook's 13F filing for Q3 2017, filed 31 Oct 2017.